Drug Shortage Report for TEVA-OXYCOCET

Last updated on 2018-02-22 History
Report ID 2983
Drug Identification Number 00608165
Brand name RATIO-OXYCOCET
Common or Proper name OXYCOCET
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACETAMINOPHEN OXYCODONE HYDROCHLORIDE
Strength(s) 325MG 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 U/D
ATC code N02AJ
ATC description
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-06-01
Estimated end date 2018-02-28
Actual end date 2018-02-21
Shortage status Resolved
Updated date 2018-02-22
Company comments Partial releases throughout recovery period
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2018-02-22 English Compare
v15 2018-02-21 French Compare
v14 2018-02-21 English Compare
v13 2018-02-21 French Compare
v12 2018-02-21 English Compare
v11 2017-12-15 French Compare
v10 2017-12-15 English Compare
v9 2017-10-10 French Compare
v8 2017-10-10 English Compare
v7 2017-09-05 French Compare
v6 2017-09-05 English Compare
v5 2017-06-27 French Compare
v4 2017-06-27 English Compare
v3 2017-05-02 English Compare
v2 2017-03-15 French Compare
v1 2017-03-15 English Compare

Showing 1 to 16 of 16